Julio Lamprea Montealegre, MD, PhD, MPH

Limonte CP, Lamprea-Montealegre JA, Tuttle KR. Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease. Seminars in nephrology 2024. PMID: 38705774

Lamprea-Montealegre JA, Shapiro A, Bontrager NAB, Rifkin DE, Jassal SK, Gregg LP, Navaneethan SD, Navarra K, Shlipak MG, Estrella MM, Wang V. Cystatin C Use for CKD Detection in the Veterans Health Administration System: A Qualitative Study of Barriers and Facilitators. Kidney Medicine 2024. PMID: 38799784

Moloney K, Lamprea Montealegre JA, Busch Isaksen TM, Kennedy M, Archer M, Contreras C, Iyaz D, Randazza J, Silva J, Errett NA. Assessing community-level impacts of and responses to stay at home orders: The King County COVID-19 community study. PloS one 2024. PMID: 38330074

Lamprea-Montealegre JA. Unlocking the potential: boosting SGLT2 inhibitor uptake to prevent the cardiorenal consequences of chronic kidney disease. The Lancet regional health. Western Pacific 2024. PMID: 38292307

Lamprea-Montealegre JA, Estrella MM. Population-wide albuminuria screening: implications for CKD detection and management. Lancet (London, England) 2023. PMID: 37597525

Chu CD, Xia F, Du Y, Singh R, Tuot DS, Lamprea-Montealegre JA, Gualtieri R, Liao N, Kong SX, Williamson T, Shlipak MG, Estrella MM. Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease. JAMA network open 2023. PMID: 37498594

Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Chu CD, Peralta CA, Du Y, Singh R, Kong SX, Tuot DS, Shlipak MG, Estrella MM. Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease. Diabetes care 2022. PMID: 36156061

Lamprea-Montealegre JA, Natarajan P. Launching a career as a physician-scientist. Heart (British Cardiac Society) 2022. PMID: 36307207

Lamprea-Montealegre JA, Joshi P, Shapiro AS, Madden E, Navarra K, Potok OA, Gregg LP, Podchiyska T, Robinson A, Goldstein MK, Peralta CA, Jassal SK, Navaneethan SD, Rifkin DE, Wang V, Shlipak MG, Estrella MM. Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol. BMC nephrology 2022. PMID: 36224528

Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Peralta C, Neilands TB, Garcia PK, Muiru A, Karliner L, Shlipak MG, Estrella MM. Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System. JAMA 2022. PMID: 36066519

Lamprea-Montealegre JA, Arnold AM, McCLelland RL, Mukamal KJ, Djousse L, Biggs ML, Siscovick DS, Tracy RP, Beisswenger PJ, Psaty BM, Ix JH, Kizer JR. Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts. Journal of the American Heart Association 2022. PMID: 35904195

Lamprea-Montealegre JA. Improving cardiovascular health through healthy lifestyle behaviours: time to think beyond willpower. Heart (British Cardiac Society) 2022. PMID: 35121577

Chu CD, Lamprea-Montealegre JA, Estrella MM. Too Many for Too Few: Finding Appropriate Nephrology Referrals for Patients With CKD That Optimize Outcomes. 2022. PMID: 35031165

Lamprea-Montealegre JA, Oyetunji S, Bagur R, Otto CM. Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9. Journal of the American College of Cardiology 2021. PMID: 34886971

Sri Lekha Tummalapalli; Julio Lamprea Montealegre; Neil Warnock; Michael Green; Said A. Ibrahim; Michelle M. Estrella. Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types JAMA health forum 2021. PMID:

Lamprea-Montealegre JA, Katz R, Scharnagl H, Silbernagel G, März W, Drechsler C, Wanner C, de Boer IH. Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis. The American journal of cardiology 2021. PMID: 34108090

Lamprea-Montealegre JA, Otto CM. Aortic and mitral valve calcification as markers of atherosclerotic cardiovascular disease risk. European heart journal. Cardiovascular Imaging 2021. PMID: 33164050

Lamprea-Montealegre JA, Shlipak MG, Estrella MM. Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention. Heart (British Cardiac Society) 2021. PMID: 33568433

Lamprea-Montealegre JA, Staplin N, Herrington WG, Haynes R, Emberson J, Baigent C, de Boer IH, SHARP Collaborative Group. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD. Clinical journal of the American Society of Nephrology : CJASN 2019. PMID: 31831577

Lamprea-Montealegre JA, McClelland RL, Otvos JD, Mora S, Koch M, Jensen MK, de Boer IH. Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis. Journal of the American Heart Association 2019. PMID: 31818211

Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, Shafi T, Go AS, Bansal N. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association 2019. PMID: 31379242

Lamprea-Montealegre JA, Zelnick LR, Hall YN, Bansal N, de Boer IH. Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis. Hypertension (Dallas, Tex. : 1979) 2018. PMID: 30354757

Lamprea-Montealegre JA, de Boer IH. Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes. Diabetes care 2018. PMID: 29784697

Boulware LE, Ephraim PL, Ameling J, Lewis-Boyer L, Rabb H, Greer RC, Crews DC, Jaar BG, Auguste P, Purnell TS, Lamprea-Monteleagre JA, Olufade T, Gimenez L, Cook C, Campbell T, Woodall A, Ramamurthi H, Davenport CA, Choudhury KR, Weir MR, Hanes DS, Wang NY, Vilme H, Powe NR. Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients. BMC nephrology 2018. PMID: 29724177

Lamprea-Montealegre JA, McClelland RL, Grams M, Ouyang P, Szklo M, de Boer IH. Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease. Heart (British Cardiac Society) 2018. PMID: 29472290

Lamprea-Montealegre JA, Otto CM. Health Behaviors and Calcific Aortic Valve Disease. Journal of the American Heart Association 2018. PMID: 29431108

Lamprea-Montealegre JA, Sharrett AR, Matsushita K, Selvin E, Szklo M, Astor BC. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study. Atherosclerosis 2014. PMID: 24607852

Purnell TS, Auguste P, Crews DC, Lamprea-Montealegre J, Olufade T, Greer R, Ephraim P, Sheu J, Kostecki D, Powe NR, Rabb H, Jaar B, Boulware LE. Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. American journal of kidney diseases : the official journal of the National Kidney Foundation 2013. PMID: 23725972

Lamprea-Montealegre JA, McClelland RL, Astor BC, Matsushita K, Shlipak M, de Boer IH, Szklo M. Chronic kidney disease, plasma lipoproteins, and coronary artery calcium incidence: the Multi-Ethnic Study of Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 2013. PMID: 23329135

Lamprea-Montealegre JA, Astor BC, McClelland RL, de Boer IH, Burke GL, Sibley CT, O'Leary D, Sharrett AR, Szklo M. CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis. Clinical journal of the American Society of Nephrology : CJASN 2012. PMID: 22879436

Lamprea-Montealegre JA, Gomez-Restrepo C.. Validity in scale-testing 2007. PMID: